David Shoukry Yassa, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Equipment Contamination | 2 | 2017 | 185 | 0.270 |
Why?
|
| o-Phthalaldehyde | 1 | 2017 | 16 | 0.150 |
Why?
|
| Ethylene Oxide | 1 | 2017 | 27 | 0.150 |
Why?
|
| Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
| Equipment Reuse | 1 | 2017 | 41 | 0.150 |
Why?
|
| Bacteriophage T4 | 1 | 1997 | 35 | 0.150 |
Why?
|
| Duodenoscopes | 1 | 2017 | 44 | 0.150 |
Why?
|
| Ethambutol | 1 | 2017 | 60 | 0.150 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2017 | 76 | 0.150 |
Why?
|
| Sterilization | 1 | 2017 | 133 | 0.140 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2016 | 26 | 0.140 |
Why?
|
| Guideline Adherence | 2 | 2018 | 2266 | 0.140 |
Why?
|
| Disinfectants | 1 | 2017 | 116 | 0.140 |
Why?
|
| Candida | 1 | 2017 | 172 | 0.140 |
Why?
|
| Microbiological Techniques | 1 | 2017 | 102 | 0.140 |
Why?
|
| Sparganosis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Spirometra | 1 | 2015 | 5 | 0.130 |
Why?
|
| Disinfection | 1 | 2017 | 191 | 0.130 |
Why?
|
| Candidiasis | 1 | 2017 | 366 | 0.120 |
Why?
|
| Cross Infection | 3 | 2018 | 1416 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 2 | 2017 | 538 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2017 | 328 | 0.110 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 567 | 0.110 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 425 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 638 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 738 | 0.100 |
Why?
|
| Mastitis | 1 | 2011 | 41 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1401 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2017 | 771 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 513 | 0.090 |
Why?
|
| Infectious Disease Medicine | 1 | 2010 | 46 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2020 | 1470 | 0.090 |
Why?
|
| Viral Proteins | 1 | 1997 | 1900 | 0.090 |
Why?
|
| Spine | 1 | 2016 | 1145 | 0.090 |
Why?
|
| Intensive Care Units | 3 | 2018 | 3680 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2019 | 1480 | 0.080 |
Why?
|
| Abscess | 1 | 2011 | 607 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 1440 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1772 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 1540 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 2987 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1438 | 0.070 |
Why?
|
| Infection Control | 3 | 2018 | 964 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 1451 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2010 | 743 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1400 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 1997 | 7879 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2016 | 3712 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2019 | 75 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15538 | 0.040 |
Why?
|
| Soaps | 1 | 2018 | 28 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3063 | 0.040 |
Why?
|
| Chymotrypsin | 1 | 1997 | 149 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 2017 | 60 | 0.040 |
Why?
|
| Cellulose | 1 | 1997 | 123 | 0.040 |
Why?
|
| Gases | 1 | 2017 | 197 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 2759 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 277 | 0.030 |
Why?
|
| Food Parasitology | 1 | 2015 | 6 | 0.030 |
Why?
|
| Praziquantel | 1 | 2015 | 25 | 0.030 |
Why?
|
| Hygiene | 1 | 2016 | 98 | 0.030 |
Why?
|
| Laminectomy | 1 | 2016 | 234 | 0.030 |
Why?
|
| Anura | 1 | 2015 | 86 | 0.030 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 339 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 761 | 0.030 |
Why?
|
| Foodborne Diseases | 1 | 2015 | 39 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1997 | 354 | 0.030 |
Why?
|
| Boston | 2 | 2020 | 9311 | 0.030 |
Why?
|
| Antiparasitic Agents | 1 | 2015 | 41 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 610 | 0.030 |
Why?
|
| Health Personnel | 2 | 2019 | 3216 | 0.030 |
Why?
|
| Food Contamination | 1 | 2015 | 189 | 0.030 |
Why?
|
| KB Cells | 1 | 1993 | 14 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 281 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1997 | 839 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 642 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1586 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 978 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2018 | 1183 | 0.030 |
Why?
|
| Logistic Models | 2 | 2016 | 13409 | 0.020 |
Why?
|
| Hand | 1 | 2016 | 884 | 0.020 |
Why?
|
| Humans | 15 | 2020 | 744220 | 0.020 |
Why?
|
| China | 1 | 2015 | 2247 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 1320 | 0.020 |
Why?
|
| Middle Aged | 6 | 2020 | 213367 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 3772 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 57768 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2016 | 1241 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1993 | 1608 | 0.020 |
Why?
|
| Female | 7 | 2020 | 380197 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2011 | 1086 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 163253 | 0.020 |
Why?
|
| Time Factors | 2 | 2017 | 40063 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10949 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5096 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2569 | 0.020 |
Why?
|
| HIV Infections | 1 | 2010 | 16718 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
| Risk Factors | 3 | 2016 | 72280 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12244 | 0.010 |
Why?
|
| Breast | 1 | 2011 | 1969 | 0.010 |
Why?
|
| Male | 5 | 2020 | 350027 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 3769 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2017 | 53280 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7179 | 0.010 |
Why?
|
| Adult | 4 | 2017 | 214035 | 0.010 |
Why?
|
| Young Adult | 2 | 2017 | 56436 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77426 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9647 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21752 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1993 | 121 | 0.010 |
Why?
|
| Physicians | 1 | 2010 | 4564 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 25618 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1993 | 595 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29142 | 0.010 |
Why?
|
| United States | 1 | 2017 | 69867 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40559 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 85759 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1227 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1993 | 2220 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1993 | 5180 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1993 | 2440 | 0.000 |
Why?
|
| Animals | 1 | 2015 | 168788 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1993 | 8437 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7799 | 0.000 |
Why?
|